Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is GEFITINIB, with a corresponding US DMF Number 29772.
Remarkably, this DMF maintains an Active status since its submission on September 24, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 11, 2016, and payment made on September 24, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II